DANIEL CHALMERS LTD
Executive Summary
Daniel Chalmers Ltd operates as a micro-scale dispensing chemist within the competitive UK retail pharmacy sector, currently exhibiting financial stress with negative net assets and working capital deficits. While its niche positioning allows for personalised service, the company faces significant challenges from sector-wide reimbursement pressures and competition from larger chains and online providers. Without addressing liquidity and capital constraints, sustaining growth or market presence in this evolving industry may prove difficult.
View Full Analysis Report →Company Documents
| Date | Description |
|---|---|
| 20/05/2520 May 2025 | Micro company accounts made up to 2024-08-31 |
| 31/08/2431 August 2024 | Annual accounts for year ending 31 Aug 2024 |
| 22/08/2422 August 2024 | Confirmation statement made on 2024-08-13 with updates |
| 20/10/2320 October 2023 | Micro company accounts made up to 2023-08-31 |
| 31/08/2331 August 2023 | Annual accounts for year ending 31 Aug 2023 |
| 15/08/2315 August 2023 | Confirmation statement made on 2023-08-13 with no updates |
| 10/08/2310 August 2023 | Change of details for Daniel Joseph Chalmers as a person with significant control on 2023-08-06 |
| 10/08/2310 August 2023 | Registered office address changed from 109 Worcester Walk Birmingham B37 5NY England to 6 Chelmsley Lane Birmingham B37 7BG on 2023-08-10 |
| 10/08/2310 August 2023 | Director's details changed for Daniel Joseph Chalmers on 2023-08-06 |
| 17/11/2217 November 2022 | Micro company accounts made up to 2022-08-31 |
| 31/08/2231 August 2022 | Annual accounts for year ending 31 Aug 2022 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company